Ranbaxy Lipitor settlement challenged in US antitrust appeal at Third Circuit
Plaintiffs alleging that Ranbaxy entered into an illegal agreement that delayed entry of a generic version of cholesterol medication Lipitor urged a US appeals court Tuesday in Philadelphia to allow their...To view the full article, register now.
Already a subscriber? Click here to view full article